This comprehensive review outlines the pathophysiology, treatments, and short- and long-term outcomes of Multisystem Inflammatory Syndrome in Children over the past five years.
This review summarizes the pathophysiology, treatments, and outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) over the past five years.
Multisystem Inflammatory Syndrome in Children: A Comprehensive Review over the Past Five Years This review explores many facets of Multisystem Inflammatory Syndrome in Children (MIS-C) over the previous 5 years. In the time since the COVID 19 pandemic gripped our medical systems, we can now explore the data that has been collected from the previous years. The literature has allowed us to better understand the impact of COVID 19 and the post illness occurrence of a severe systemic inflammatory disease on our youngest patient populations. This paper will outline the pathophysiology of MIS-C, the treatments utilized, short and long-term patient outcomes including epidemiological factors.
Shyong et al. (2025) conducted a review in Multisystem Inflammatory Syndrome in Children (MIS-C). This comprehensive review outlines the pathophysiology, treatments, and short- and long-term outcomes of Multisystem Inflammatory Syndrome in Children over the past five years.